WIRB-Copernicus Group Biosafety Expert to Lead Three Sessions at Campus Safety Health and Environmental Management Association (CSHEMA) Annual Conference
Presentations will help attendees to increase their biosafety management
and risk assessment skills
PRINCETON, N.J., July 17, 2015 – WIRB-Copernicus Group® (WCG™), the world’s largest provider of regulatory and ethical review services and software to support clinical research, announced today that its Senior Vice President of Biosafety and Gene Therapy Chris Jenkins, PhD, MPH, RBP, CHMM, will lead three sessions at the Campus Safety Health and Environmental Management Association (CSHEMA) Annual Conference being held in Washington, DC from July 17-22.
“Environmental health and safety (EHS) professionals have a complicated job. They are tasked with managing a broad range of biohazards, protecting human subjects, investigators and on-site personnel, and maintaining laboratory and workspace security,” said Dr. Jenkins. “We are proud to partner with CSHEMA and our industry colleagues to ensure that these important staff members receive the most up-to-date and comprehensive biosafety training possible.”
Dr. Jenkins will cover pertinent public health and regulatory issues and describe best practices for effective institutional oversight of biological materials in a seminar, “Biosafety Institutions: An Overview for EHS Managers,” on Friday, July 17 from 1-5 p.m. This session will teach EHS directors, managers, and safety professionals how to ask the right questions and find the right answers to protect their community.
On Saturday, July 18, Dr. Jenkins will present an all-day Biosafety Training Course with Kalpana Rengarajan, PhD, associate director at the Environmental Health and Safety Office, Emory University. This course is designed to teach biosafety principles to people who are new to the field. In the first half of the class, Drs. Jenkins and Rengarajan will discuss general biosafety topics such as biohazard exposure, control measures, disinfection, spills, medical surveillance, laboratory-acquired infections, shipping and regulatory issues. In the second half of the class, they will apply those biosafety principles to conduct risk assessment exercises, and examine biosafety program and biorisk management issues.
Then on Wednesday, July 22, Dr. Jenkins will co-present a seminar, “Using External Resources to Enhance EHS Programs,” with Rebecca Seevers, MS, CIH, director of environmental health and safety at Medical College of Wisconsin, from 11:45 a.m. – 12:15 p.m. EHS organizations are required to manage a wide array of biological, chemical, radiation and general safety issues. During this session, Dr. Jenkins and Ms. Seevers will give advice on how to engage external resources from an industry and an academic perspective.
Dr. Jenkins specializes in providing biosafety consulting and overseeing research compliance with higher-risk biological materials ranging from human gene transfer to select agents and toxins. He oversees more than 200 Institutional Biosafety Committees in universities, private research institutes, and clinical settings.
For further information about this conference, please visit http://www.cshema.org/dc.
About WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world’s largest provider of regulatory and ethical solutions for clinical research. The company provides Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) reviews, and Human Research Protection (HRP), Good Clinical Practice (GCP) and Biosafety consulting services. Its technology offerings include IRB workflow management solutions (IRBNet), clinical trial management software for sponsors and contract research organizations (ePharmaSolutions), and Part-11 compliant online learning solutions for research professionals (WCG Academy).
The pioneer of independent ethical oversight, WCG continues to drive progress in the clinical research space. WCG empowers clients to accelerate life-saving advancements, while ensuring that the risks of progress never outweigh the value of human life.
For more information, please visit www.wcgclinical.com or follow us on Twitter @WCGClinical.
Download the Press Release